Your Brain Matter, Matters

When it comes to brain health, you and your loved ones deserve as much clarity and accuracy as possible. That’s why Qynapse is dedicated to providing you and your physician with an objective view of your brain health.

Clarity, precision and results you can trust for more peace of mind.

For those facing the onset of a central nervous system (CNS) disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis, and for those wondering if one is on the horizon, Qynapse offers a clearer and more objective view of your brain health.

QyScore®, our FDA-Cleared, CE-marked neuroimaging software platform, takes an MRI scan, applies our high-performing algorithms, rapidly analyzes, compares to age-matched controls and produces automated brain measures in an easy-to-use patient report. This offers your healthcare provider precise, accurate and objective data that has the potential to reduce the time to diagnosis, facilitate smooth therapeutic switches and personalize your long-term care plan.

With a better understanding of your MRI scans earlier, your physician can recommend timely intervention methods to you and your loved ones which could improve your quality of life and outcome with fewer clinical visits. Empower planning with more clarity, earlier.

Our technology is a game changer.

With global support from the most renowned and respected CNS disease experts, QyScore® has demonstrated superior performance compared to certain other automated state-of-the-art methods and has been validated against gold-standard manual segmentation.

Our AI-powered and proprietary neuroimaging software platform, QyScore®, produces a wide range of automated neuroimaging biomarkers to assist physicians making clinical care decisions and monitoring patients over time.

QyScore® is FDA-Cleared and CE-Marked

Better Awareness

Potential to increase patient and caregiver awareness of diagnosis

Time to Diagnosis

Qynapse has the potential to reduce time to diagnosis

Timely Intervention

Potential to support early intervention and better patient outcomes

Your brain matter, matters. Qynapse provides you and your health practitioner a clearer and more objective view of your brain health.

Qyscore® is a medical device software FDA-cleared – class II and CE-marked – class IIa.

Indications for Use in the U.S. (FDA): QyScore® is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images. Volumetric data may be compared to reference percentile data. QyScore® is not intended for use in clinical scenarios that require evaluation of the number of the white matter hyperintensities.

Indications for Use in Europe (CE): QyScore® is an advanced processing and visualization software for automatic labeling and volumetric quantification of segmented central nervous system structures for patients older than 18 years of age. The software is intended to be used by medical personnel or neuroimaging trained personnel to support diagnosis of central nervous system diseases.